FDA Inspection 1260661 — EUROAPI FRANCE
The FDA completed an inspection of EUROAPI FRANCE on March 8, 2024 in Vertolaye. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 8, 2024
- Fiscal Year
- 2024
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Vertolaye (France)
Additional Details
Mutual Recognition Agreement (MRA)